DK98884D0 - Human beta-nervevaekstfaktor og fremg. til fremst. deraf, dna-sekvens, som koder for faktoren, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farma. praeparat og anven. af faktoren til behand. af beskadigede nerver - Google Patents

Human beta-nervevaekstfaktor og fremg. til fremst. deraf, dna-sekvens, som koder for faktoren, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farma. praeparat og anven. af faktoren til behand. af beskadigede nerver

Info

Publication number: DK98884D0
Authority: DK; Denmark
Prior art keywords: factor; dna sequence; vector; recombinant; farma
Prior art date: 1983-03-03

Application number

DK0988/84A

Other languages

English (en)

Other versions

DK161152B (da

DK98884A (da

DK161152C (da

Inventor

Alane Molly Gray

Axel Ullrich

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-03-03

Filing date

1984-02-24

Publication date

1984-02-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23873671&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK98884(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1984-02-24 Application filed by Genentech Inc filed Critical Genentech Inc

1984-02-24 Publication of DK98884D0 publication Critical patent/DK98884D0/da

1984-10-04 Publication of DK98884A publication Critical patent/DK98884A/da

1991-06-03 Publication of DK161152B publication Critical patent/DK161152B/da

1991-11-11 Application granted granted Critical

1991-11-11 Publication of DK161152C publication Critical patent/DK161152C/da

Links

108091028043 Nucleic acid sequence Proteins 0.000 title 2
101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 title 1
239000013604 expression vector Substances 0.000 title 1
239000003102 growth factor Substances 0.000 title 1
102000055647 human CSF2RB Human genes 0.000 title 1
210000005036 nerve Anatomy 0.000 title 1
FIAFUQMPZJWCLV-UHFFFAOYSA-N suramin Chemical compound OS(=O)(=O)C1=CC(S(O)(=O)=O)=C2C(NC(=O)C3=CC=C(C(=C3)NC(=O)C=3C=C(NC(=O)NC=4C=C(C=CC=4)C(=O)NC=4C(=CC=C(C=4)C(=O)NC=4C5=C(C=C(C=C5C(=CC=4)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)C)C=CC=3)C)=CC=C(S(O)(=O)=O)C2=C1 FIAFUQMPZJWCLV-UHFFFAOYSA-N 0.000 title 1
239000013598 vector Substances 0.000 title 1
102000015336 Nerve Growth Factor Human genes 0.000 abstract 1
108010025020 Nerve Growth Factor Proteins 0.000 abstract 1
108020004511 Recombinant DNA Proteins 0.000 abstract 1
229940053128 nerve growth factor Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Gastroenterology & Hepatology (AREA)
Neurosurgery (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Neurology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK098884A 1983-03-03 1984-02-24 Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat DK161152C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US47196283A	1983-03-03	1983-03-03
US47196283		1983-03-03

Publications (4)

Publication Number	Publication Date
DK98884D0 true DK98884D0 (da)	1984-02-24
DK98884A DK98884A (da)	1984-10-04
DK161152B DK161152B (da)	1991-06-03
DK161152C DK161152C (da)	1991-11-11

Family

ID=23873671

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK098884A DK161152C (da)	1983-03-03	1984-02-24	Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat

Country Status (12)

Country	Link
EP (1)	EP0121338B2 (da)
JP (4)	JPS6084299A (da)
KR (1)	KR840008026A (da)
AT (1)	ATE45382T1 (da)
AU (1)	AU574350B2 (da)
CA (1)	CA1220736A (da)
DE (1)	DE3479321D1 (da)
DK (1)	DK161152C (da)
ES (1)	ES530202A0 (da)
IE (1)	IE57013B1 (da)
NZ (1)	NZ207337A (da)
ZA (1)	ZA841597B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE105868T1 (de) *	1985-09-12	1994-06-15	Scios Nova Inc	Rekombinanter fibroblast-wachstumsfaktor.
JPH01102096A (ja) *	1987-10-15	1989-04-19	Sanwa Kagaku Kenkyusho Co Ltd	モチリン様活性を有するポリペプチド、その発現用微生物及び該ポリペプチドの製法
JPH01211490A (ja) *	1988-02-19	1989-08-24	Tosoh Corp	ヒト神経成長因子遺伝子セグメント
IT1219874B (it) *	1988-03-18	1990-05-24	Fidia Farmaceutici	Utilizzazione del fattore di crescita nervoso umano e sue composizioni farmaceutiche
US5134121A (en) *	1988-03-28	1992-07-28	Regents Of The University Of California	Nerve growth factor peptides
US5683894A (en) *	1988-04-29	1997-11-04	University Of California	Recombinant nerve growth factor
JPH0771509B2 (ja) *	1988-07-12	1995-08-02	工業技術院長	ヒトβ−ＮＧＦの発現法
US5082774A (en) *	1988-08-30	1992-01-21	The General Hospital Corporation	Recombinant human nerve growth factor
US5272063A (en) *	1988-11-22	1993-12-21	Syntex (U.S.A.) Inc.	Process of making human nerve growth factor
US6709837B1 (en)	1989-03-10	2004-03-23	Takeda Chemical Industries, Inc.	Polypeptide and production thereof
SE8901715L (sv) *	1989-05-12	1990-11-13	Lope Medicine Ab	En plasmid dna-konstruktion innehaallande dna-sekvenser
IT1232157B (it) *	1989-07-20	1992-01-25	Fidia Farmaceutici	Purificazione del fattore di crescita nervoso tramite cromatografia a scambio di subunita'
DE69017793T2 (de) *	1989-08-21	1995-08-24	Takeda Chemical Industries Ltd	Produktion von menschlichen Nervenwachstumsfaktoren.
US5656435A (en) *	1989-08-28	1997-08-12	Takeda Chemical Industries, Ltd.	Antibodies to peptides having NGF-like activity, said antibodies having no substantial cross-reactivity with NGF, and use thereof
US6933276B1 (en)	1989-08-30	2005-08-23	Regeneron Pharmaceuticals, Inc.	Methods of treating peripheral neuropathies using neurotrophin-3
IL95511A (en) *	1989-08-30	2000-10-31	Max Planck Gesellschaft	Neurotrophin-3 a novel neurotrophic factor related to nerve growth and brain derived neurotrophic factor
US5180820A (en) *	1989-08-30	1993-01-19	Barde Yves Alain	Brain-derived neurotrophic factor
IT1238348B (it) *	1989-11-16	1993-07-13		Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.
JPH03244385A (ja) *	1990-02-21	1991-10-31	Hitachi Ltd	ヒト神経成長因子の遺伝子工学的生産方法
IT1239271B (it) *	1990-02-27	1993-10-01	Fidia Spa	Processo per l'espressione del fattore di crescita nervoso umano in cellule di artropoda frugiperda via infezione con baculovirus ricombinante
US5606031A (en) *	1990-04-06	1997-02-25	Lile; Jack	Production and purification of biologically active recombinant neurotrophic protein in bacteria
US5986070A (en) *	1990-04-06	1999-11-16	Amgen Inc.	Production of biologically active NGF proteins
US5235043A (en) *	1990-04-06	1993-08-10	Synergen, Inc.	Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
US5389529A (en) *	1991-06-12	1995-02-14	Regeneron Pharmaceuticals, Inc.	Modified lamβ signal sequence and processes for producing recombinant neurotrophins
PT100580A (pt) *	1991-06-12	1993-09-30	Regeneron Pharma	Producao e recuperacao de neurotrofinas recombinantes
DE4139000A1 (de) *	1991-11-27	1993-06-03	Boehringer Mannheim Gmbh	Verfahren zur gentechnologischen herstellung von biologisch aktivem ss-ngf
US6063757A (en) *	1995-11-29	2000-05-16	Urso; Richard G.	Wound treatment method with nerve growth factor
US6566094B1 (en) *	1996-09-11	2003-05-20	Sumitomo Pharmaceuticals Company, Limited	Semaphorin gene: Semaphorin Y
ES2293662T3 (es)	1996-11-15	2008-03-16	Genentech, Inc.	Purificacion de neurotrofinas.
EP0977778A2 (en) *	1997-02-06	2000-02-09	Hoechst Marion Roussel, Inc.	Human nerve growth factor exon 1 and exon 3 promoters
US6197551B1 (en) *	1998-01-27	2001-03-06	Millennium Pharmaceuticals, Inc.	Spoil-1 protein and nucleic acid molecules and uses therefor
ITRM20050045A1 (it) *	2005-02-02	2006-08-03	Consiglio Nazionale Ricerche	Proteina isolata da eisenia foetida simile all'ngf umano e usi relativi.
US7294384B2 (en)	2005-09-27	2007-11-13	Milliken & Company	Moldable construction incorporating bonding interface
US7378359B2 (en)	2005-09-27	2008-05-27	Eleazer Howell B	Moldable fibrous construction incorporating non-woven layers
US7300691B2 (en)	2005-09-27	2007-11-27	Milliken & Company	Moldable construction incorporating non-olefin bonding interface
US20080124513A1 (en)	2006-09-11	2008-05-29	Eleazer Howell B	Moldable fabric with unidirectional tape yarns
JP6767688B2 (ja)	2015-05-20	2020-10-14	パナソニックＩｐマネジメント株式会社	室内空調システム
IT202000005542A1 (it)	2020-03-16	2021-09-16	Themis S R L	Metodo cosmetico per il trattamento della pelle e per la ricrescita dei capelli

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4185095A (en) *	1977-11-23	1980-01-22	The Massachusetts General Hospital	Nerve growth factor
ZA811368B (en) †	1980-03-24	1982-04-28	Genentech Inc	Bacterial polypedtide expression employing tryptophan promoter-operator

1984
- 1984-02-24 DK DK098884A patent/DK161152C/da not_active IP Right Cessation
- 1984-03-01 ES ES530202A patent/ES530202A0/es active Granted
- 1984-03-01 IE IE493/84A patent/IE57013B1/en not_active IP Right Cessation
- 1984-03-01 NZ NZ207337A patent/NZ207337A/en unknown
- 1984-03-02 KR KR1019840001051A patent/KR840008026A/ko not_active Ceased
- 1984-03-02 EP EP84301377A patent/EP0121338B2/en not_active Expired - Lifetime
- 1984-03-02 ZA ZA841597A patent/ZA841597B/xx unknown
- 1984-03-02 AU AU25252/84A patent/AU574350B2/en not_active Expired
- 1984-03-02 JP JP59041205A patent/JPS6084299A/ja active Granted
- 1984-03-02 AT AT84301377T patent/ATE45382T1/de not_active IP Right Cessation
- 1984-03-02 CA CA000448766A patent/CA1220736A/en not_active Expired
- 1984-03-02 DE DE8484301377T patent/DE3479321D1/de not_active Expired
1992
- 1992-07-13 JP JP4185044A patent/JP2740417B2/ja not_active Expired - Lifetime
- 1992-12-25 JP JP4346109A patent/JPH067169A/ja active Pending
- 1992-12-25 JP JP4346116A patent/JP2898494B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU2525284A (en)	1984-09-06
ES8600783A1 (es)	1985-11-01
JPH067169A (ja)	1994-01-18
JP2898494B2 (ja)	1999-06-02
CA1220736A (en)	1987-04-21
ES530202A0 (es)	1985-11-01
ATE45382T1 (de)	1989-08-15
NZ207337A (en)	1987-11-27
EP0121338B1 (en)	1989-08-09
JPH0536031B2 (da)	1993-05-28
ZA841597B (en)	1984-10-31
EP0121338A1 (en)	1984-10-10
JPS6084299A (ja)	1985-05-13
AU574350B2 (en)	1988-07-07
EP0121338B2 (en)	1999-10-27
IE840493L (en)	1984-09-03
DE3479321D1 (en)	1989-09-14
JPH0690764A (ja)	1994-04-05
KR840008026A (ko)	1984-12-12
DK161152B (da)	1991-06-03
DK98884A (da)	1984-10-04
JP2740417B2 (ja)	1998-04-15
IE57013B1 (en)	1992-03-11
DK161152C (da)	1991-11-11
JPH05310792A (ja)	1993-11-22

Similar Documents

Publication	Publication Date	Title
DK98884A (da)	1984-10-04	Human beta-nervevaekstfaktor og fremg. til fremst. deraf, dna-sekvens, som koder for faktoren, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farma. praeparat og anven. af faktoren til behand. af beskadigede nerver
NO166943C (no)	1991-09-18	Analogifremgangsmaate for fremstilling av enzymresistente immunomodulerende peptider.
DK224587A (da)	1987-05-01	Ekstracellulaer superoxiddismutase (ec-sod), dna-fragment, der indkoder ec-sod, fremgangsmaade til fremstilling af ec-sod samt anvendelse af ec-sod
ES8603955A1 (es)	1986-01-16	Preparacion de igf y egf de humano por tecnologia de adn recombinante
ES9000011A1 (es)	1990-03-01	Procedimiento para transformar un cultivo de celulas de modo que produzca activador de plasminogeno de tejido (t-pa) humano
DK623587D0 (da)	1987-11-27	Plantevaekstregulerende middel og anvendelse af dette til regulering af plantevaekst
IT8484131A0 (it)	1984-09-28	Procedimento per la produzione di ossigeno mediante apparecchiatura portatile, particolarmente per respirazione umana, ed apparecchiatura per attuare il procedimento.
DK320687D0 (da)	1987-06-24	Fremgangsmaade og anlaeg til behandling med ammoniak
PL266680A1 (en)	1988-07-07	Method of obtaining il-6 and of its application
DK268882A (da)	1983-02-02	Fremgangsmaade til fremstilling af et polypeptid, dna-sekvens, som koder for polypeptidet, replicerbart mikrobielt udtrykkelsesmedium, som i en transformant-mikroorganisme er i stand til at udtrykke polypeptidet og kultur af en mikroorganisme transformeret dermed
BG60238B1 (bg)	1994-01-24	Човешки тумор- некротизиращ фактор
DK432987A (da)	1987-08-19	Fremgangsmaade til forbedring af ekspressionen af eukaryotprotein
BG41136A3 (bg)	1987-04-15	Метод за получаване на днк преносен вектор,предназначен за поддържане и репликация на дезоксинуклеотидна последователност, кодираща човешки проинсулин
PT83733B (pt)	1988-08-17	Processo para a preparacao de tiozolonas com actividade cardiotonica
IT8422918A0 (it)	1984-09-28	Procedimento di calcinazione dicorpi carboniosi, in particolare elettrodi, in forni continui od intermittenti e struttura dicontenimento per effettuare il procedimento.
DK179384D0 (da)	1984-04-05	Interferon og interferoninducere kombineret med tobaksprodukter
DK489086A (da)	1987-04-16	Tetradecapeptider med mitogen aktivitet og fremgangsmaade til stimulering af vaeksten af macrophag-lignende celler
DK100785A (da)	1985-09-08	Midler til stimulering af haarvaekst
DK285587D0 (da)	1987-06-03	Ekspressionsvektor med evne til inducibar ekspression af et fremmed strukturgen, der baeres af ekspressionsvektoren, i vaertsceller og fremgangsmaade tilfremstilling af oenskede genprodukter
DK171825B1 (da)	1997-06-23	DNA, som koder for human protein S herunder et polypeptid med human protein S-aktivitet, DNA-vektorer, værtsceller herunder cellekulturer, som er transformeret med disse vektorer, fremgangsmåde til fremstilling af human protein S, humant protein S fremstillet ved fremgangsmåden samt farmaceutisk middel, der består af humant protein S
DK129184A (da)	1985-08-30	Fremgangsmaade til regulering af stroemmen i et anlaeg til elektrolytisk vandbehandling
HE et al.	1981	THE EFFECT OF REMOTE SEGMENTAL ELECTRO-ACUPUNCTURE ON THE FLEXION REFLEX POTENTIAL AND THE DORSAL ROOT POTENTIAL
PL204515A1 (pl)	1979-10-08	Sposob zasilania odbiorow szczegolnie samoczynnej blokady liniowej i uklad do stosowania tego sposobu
ES8703928A1 (es)	1987-03-01	Un metodo para preparar la proteina factor de estimulacion de colonias (csf-1)recombinante
UA6064A1 (uk)	1994-12-29	Спосіб визначення активності туберкульозу легень

Legal Events

Date	Code	Title	Description
2004-03-15	PUP	Patent expired